Stockscreener 앱 받기
4.80
3.81%
-0.19
시간 외 거래:
4.76
-0.04
-0.83%
전일 마감가:
$4.99
열려 있는:
$5
하루 거래량:
231.56K
Relative Volume:
1.35
시가총액:
$115.54M
수익:
$52.29M
순이익/손실:
$-73.52M
주가수익비율:
-7.2727
EPS:
-0.66
순현금흐름:
$-100.45M
1주 성능:
+0.84%
1개월 성능:
-18.37%
6개월 성능:
-2.04%
1년 성능:
-11.76%
1일 변동 폭
$4.75
$5.04
1주일 범위
$4.61
$5.20
52주 변동 폭
$3.61
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
명칭
Precision Biosciences Inc
전화
919-314-5512
주소
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
4.80 | 120.12M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 개시 | Guggenheim | Buy |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-09 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 재개 | BTIG Research | Buy |
| 2020-04-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-05 | 개시 | Stifel | Buy |
| 2020-02-25 | 개시 | William Blair | Outperform |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | H.C. Wainwright | Buy |
| 2019-04-22 | 개시 | Barclays | Overweight |
| 2019-04-22 | 개시 | Goldman | Buy |
| 2019-04-22 | 개시 | JP Morgan | Overweight |
| 2019-04-22 | 개시 | Jefferies | Buy |
모두보기
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
Financial Analysis: Precision BioSciences (NASDAQ:DTIL) & Upstream Bio (NASDAQ:UPB) - Defense World
Aug Summary: Can Precision BioSciences Inc stock hit analyst price targetsWeekly Trading Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Block Trades: Is Precision BioSciences Inc stock resilient to inflationBuy Signal & Comprehensive Market Scan Reports - BỘ NỘI VỤ
Precision BioSciences launches $75M stock and warrant offering - MSN
Is Precision BioSciences Inc. stock resilient to inflationJuly 2025 Decliners & Consistent Return Strategy Ideas - Newser
Can Precision BioSciences Inc. (PBS0) stock ride next bull market cycleWeekly Trading Summary & AI Enhanced Trading Signals - Newser
Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha
Why Precision BioSciences Inc. (PBS0) stock is a strong buy callJuly 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
How Precision BioSciences Inc. stock reacts to oil pricesQuarterly Profit Review & Reliable Breakout Forecasts - Newser
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunity - Newser
Precision BioSciences (DTIL) Stock Analysis Report | Financials & Insights - Benzinga
Will Precision BioSciences Inc. (PBS0) stock announce a stock split2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - Newser
How Precision BioSciences Inc. (PBS0) stock compares with market leaders2025 Top Gainers & High Accuracy Buy Signal Tips - Newser
Why Precision BioSciences Inc. (PBS0) stock trades below fair valueLayoff News & Safe Entry Point Alerts - Newser
How Precision BioSciences Inc. stock compares to industry benchmarksJuly 2025 Levels & Daily Momentum Trading Reports - BỘ NỘI VỤ
Precision BioSciences (NASDAQ:DTIL) Trading 4.9% HigherTime to Buy? - MarketBeat
Will Precision BioSciences Inc. stock outperform Nasdaq indexJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn
Are Smart Investors Making the Right Decision? Precision Biosciences Inc (DTIL) - setenews.com
United StatesMintz Advises On Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mondaq
H.C. Wainwright Keeps Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail
Will Precision BioSciences Inc. stock return to pre crisis levelsLayoff News & Growth Focused Stock Reports - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIFed Meeting & Technical Confirmation Alerts - newser.com
How analysts rate Precision BioSciences Inc. stock todayMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
Will Precision BioSciences Inc. stock outperform Dow Jones indexAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
Will Precision BioSciences Inc. (PBS0) stock beat revenue estimates2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Mintz Advises on Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mintz
Precision BioSciences (DTIL) Price Target Decreased by 10.55% to 33.15 - MSN
Is Precision BioSciences Inc. stock dividend yield sustainableWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Precision BioSciences Inc. (DTIL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why pension funds invest in Precision BioSciences Inc. (PBS0) stock2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Precision BioSciences (Nasdaq: DTIL) to Present PBGENE-HBV Trial Data at Hep-DART 2025 - Stock Titan
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025 - Business Wire
Is Precision BioSciences Inc. (PBS0) stock in buy zone after pullback - newser.com
Precision Biosciences Inc (DTIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precision Biosciences Inc 주식 (DTIL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kelly John Alexander | Chief Financial Officer |
Nov 03 '25 |
Sale |
6.49 |
1,303 |
8,456 |
77,298 |
| Scimeca Dario | General Counsel and Secretary |
Nov 02 '25 |
Option Exercise |
0.00 |
1,835 |
0 |
28,923 |
| Scimeca Dario | General Counsel and Secretary |
Nov 03 '25 |
Sale |
6.49 |
665 |
4,316 |
28,258 |
| Amoroso Michael | President and CEO |
Nov 02 '25 |
Option Exercise |
0.00 |
9,444 |
0 |
118,984 |
| Amoroso Michael | President and CEO |
Nov 03 '25 |
Sale |
6.49 |
3,409 |
22,124 |
115,575 |
0.36%
1.05%
자본화:
|
볼륨(24시간):